Liposome-Micelle-Hybrid (LMH) Carriers for Controlled Co-Delivery of 5-FU and Paclitaxel as Chemotherapeutics

Paclitaxel (PTX) and 5-fluorouracil (5-FU) are clinically relevant chemotherapeutics, but both suffer a range of biopharmaceutical challenges (e.g., either low solubility or permeability and limited controlled release from nanocarriers), which reduces their effectiveness in new medicines. Anticancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Md. Musfizur, Romana, Bilquis, Mao, Guangzhao, Kumar, Naresh, Sonvico, Fabio, Thordarson, Pall, Joyce, Paul, Bremmell, Kristen E., Barnes, Timothy J., Prestidge, Clive A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385268/
https://www.ncbi.nlm.nih.gov/pubmed/37514072
http://dx.doi.org/10.3390/pharmaceutics15071886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385268/
https://www.ncbi.nlm.nih.gov/pubmed/37514072
http://dx.doi.org/10.3390/pharmaceutics15071886

Ejemplares similares